Novobind Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 12

Novobind General Information

Description

Operator of an agri-biotech company intended to combat rising resistance to anti-infectives and the build-up of dangerous residues in the environment. The company develops next-generation biologics that target and neutralize the specific bacteria, viruses, and parasites that cause intestinal ailments in livestock, aquaculture, and pets, enabling animal sector businesses to reduce wastage caused by bacteria, viruses, and parasites in aquatic and terrestrial livestock production.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1021 West Hastings
  • MNP Tower 9th Floor
  • Vancouver, British Columbia V6E 0C3
  • Canada
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Agriculture
Corporate Office
  • 1021 West Hastings
  • MNP Tower 9th Floor
  • Vancouver, British Columbia V6E 0C3
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novobind Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private Completed Generating Revenue
5. Later Stage VC (Series A) 01-Oct-2020 Completed Generating Revenue
4. Seed Round Completed Generating Revenue
3. Accelerator/Incubator 01-Mar-2017 Completed Generating Revenue
2. Grant 03-Jun-2014 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Novobind’s complete valuation and funding history, request access »

Novobind Patents

Novobind Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024092360-A1 Antibodies against aquaculture disease-causing agents and uses thereof Inactive 03-Nov-2022
WO-2023205876-A1 Antibodies against disease causing agents of plants and uses thereof Inactive 29-Apr-2022
WO-2023168357-A2 Antibodies against disease-causing agents applied to plant vascular systems Inactive 03-Mar-2022
WO-2023168357-A3 Antibodies against disease-causing agents applied to plant vascular systems Inactive 03-Mar-2022
CA-3140739-A1 Antibodies against disease causing agents of poultry and uses thereof Pending 20-May-2019 C07K16/20
To view Novobind’s complete patent history, request access »

Novobind Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novobind Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Agribusiness Advisors Venture Capital Minority
Ark Canada Investment Group Family Office Minority
Invest Nova Scotia Venture Capital Minority
Lallemand Corporation Minority
Little Green Bamboo Capital Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Novobind FAQs

  • When was Novobind founded?

    Novobind was founded in 2012.

  • Where is Novobind headquartered?

    Novobind is headquartered in Vancouver, Canada.

  • What is the size of Novobind?

    Novobind has 20 total employees.

  • What industry is Novobind in?

    Novobind’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Novobind a private or public company?

    Novobind is a Private company.

  • What is Novobind’s current revenue?

    The current revenue for Novobind is .

  • Who are Novobind’s investors?

    Agribusiness Advisors, Ark Canada Investment Group, Invest Nova Scotia, Lallemand, and Little Green Bamboo Capital are 5 of 12 investors who have invested in Novobind.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process